NATICK, Mass., April 10, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) announces CE Mark approval and European market launch of its INGENIO™ and ADVANTIO™ pacemakers and INVIVE™ cardiac ...
NATICK, Mass., April 2, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) announces the launch of its BackStop® Gel, a new technology designed to prevent stone migration during procedures ...
NATICK, Mass. and CHICAGO, March 26, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) announces its support of the HORIZONS II AMI clinical trial, which is designed to evaluate the safety ...
NATICK, Mass., March 22, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) announces the U.S. and international launch of the WallFlex ® Biliary Transhepatic Stent System.  This third-generation ...
NATICK, Mass., March 20, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX - News) releases its schedule of product-related clinical research at the 61th Annual Scientific Session of the American ...